ASR Vermogensbeheer N.V. Buys 14,977 Shares of Xylem Inc. $XYL

ASR Vermogensbeheer N.V. boosted its stake in shares of Xylem Inc. (NYSE:XYL) by 5.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 279,638 shares of the industrial products company’s stock after acquiring an additional 14,977 shares during the quarter. ASR Vermogensbeheer N.V.’s holdings in Xylem were worth $41,247,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank acquired a new stake in shares of Xylem during the 2nd quarter worth about $338,232,000. ABN AMRO Bank N.V. acquired a new position in Xylem in the second quarter valued at about $208,226,000. Swedbank AB grew its stake in Xylem by 19.0% during the third quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after buying an additional 830,821 shares during the last quarter. Amundi increased its holdings in shares of Xylem by 17.0% during the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock worth $730,717,000 after buying an additional 830,337 shares in the last quarter. Finally, Voya Investment Management LLC raised its stake in shares of Xylem by 544.0% in the third quarter. Voya Investment Management LLC now owns 868,755 shares of the industrial products company’s stock valued at $128,141,000 after acquiring an additional 733,860 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Price Performance

Shares of XYL stock opened at $146.38 on Friday. The firm has a market cap of $35.64 billion, a price-to-earnings ratio of 37.63, a PEG ratio of 2.05 and a beta of 1.17. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17. The stock has a 50-day moving average price of $140.26 and a 200 day moving average price of $141.10.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same quarter last year, the firm earned $1.11 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Research analysts expect that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were paid a $0.40 dividend. The ex-dividend date of this dividend was Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem’s dividend payout ratio (DPR) is presently 41.13%.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Zacks Research lowered Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. UBS Group increased their target price on Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. TD Cowen raised their target price on Xylem from $130.00 to $135.00 and gave the company a “hold” rating in a research note on Friday, December 5th. Stifel Nicolaus upped their price target on shares of Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Finally, Barclays lowered their price objective on shares of Xylem from $172.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, January 7th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Xylem has an average rating of “Moderate Buy” and an average price target of $165.80.

Insiders Place Their Bets

In related news, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. The trade was a 9.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the completion of the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. This represents a 25.01% decrease in their position. The SEC filing for this sale provides additional information. 0.27% of the stock is currently owned by insiders.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.